4.8 Article

B56 delta-related protein phosphatase 2A dysfunction identified in patients with intellectual disability

期刊

JOURNAL OF CLINICAL INVESTIGATION
卷 125, 期 8, 页码 3051-3062

出版社

AMER SOC CLINICAL INVESTIGATION INC
DOI: 10.1172/JCI79860

关键词

-

资金

  1. Health Innovation Challenge Fund [HICF-1009-003]
  2. Wellcome Trust
  3. Department of Health
  4. Wellcome Trust Sanger Institute [WT098051]
  5. NIH Research, through the Comprehensive Clinical Research Network
  6. KU Leuven Research Fund [OT/13/094]
  7. Research Foundation Flanders [G.0582.11]
  8. TAP program of the Belgian federal government [P7/13]
  9. Flemish Agency for Innovation by Science and Technology (IWT)
  10. Netherlands Organization for Health Research and Development [ZonMW 916-12-095]
  11. HelseVest grant [911744]
  12. EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD083091] Funding Source: NIH RePORTER
  13. NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH101221] Funding Source: NIH RePORTER

向作者/读者索取更多资源

Here we report inherited dysregulation of protein phosphatase activity as a cause of intellectual disability (ID). De novo missense mutations in 2 subunits of serine/threonine (Ser/Thr) protein phosphatase 2A (PP2A) were identified in 16 individuals with mild to severe ID, long-lasting hypotonia, epileptic susceptibility, frontal bossing, mild hypertelorism, and downslanting palpebral fissures. PP2A comprises catalytic (C), scaffolding (A), and regulatory (B) subunits that determine subcellular anchoring, substrate specificity, and physiological function. Ten patients had mutations within a highly conserved acidic loop of the PPP2R5D-encoded B56 delta regulatory subunit, with the same E198K mutation present in 6 individuals. Five patients had mutations in the PPP2R1A-encoded scaffolding A alpha subunit, with the same R182W mutation in 3 individuals. Some A alpha cases presented with large ventricles, causing macrocephaly and hydrocephalus suspicion, and all cases exhibited partial or complete corpus callosum agenesis. Functional evaluation revealed that mutant A and B subunits were stable and uncoupled from phosphatase activity. Mutant B56 delta was A and C binding-deficient, while mutant A alpha subunits bound B56 delta well but were unable to bind C or bound a catalytically impaired C, suggesting a dominant-negative effect where mutant subunits hinder dephosphorylation of B56 delta-anchored substrates. Moreover, mutant subunit overexpression resulted in hyperphosphorylation of GSK3 beta, a B56 delta-regulated substrate. This effect was in line with clinical observations, supporting a correlation between the ID degree and biochemical disturbance.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Geriatrics & Gerontology

Circulating interleukin-37 declines with aging in healthy humans: relations to healthspan indicators and IL37 gene SNPs

Vienna E. Brunt, Akpevweoghene P. Ikoba, Brian P. Ziemba, Dov B. Ballak, Alexander Hoischen, Charles A. Dinarello, Marissa A. Ehringer, Douglas R. Seals

Summary: The study investigates the role of interleukin (IL)-37 in biological aging in humans. They found that plasma IL-37 levels are lower in older adults, despite elevations in pro-inflammatory markers. The ratios of circulating IL-37 to pro-inflammatory markers were also considerably lower in older adults, indicating impaired IL-37 responsiveness to a pro-inflammatory state with aging. The study provides novel insights into the potential role of IL-37 in aging.

GEROSCIENCE (2023)

Article Biochemistry & Molecular Biology

The performance of genome sequencing as a first-tier test for neurodevelopmental disorders

Bart P. G. H. van der Sanden, Gaby Schobers, Jordi Corominas Galbany, David A. Koolen, Margje Sinnema, Jeroen van Reeuwijk, Connie T. R. M. Stumpel, Tjitske Kleefstra, Bert B. A. de Vries, Martina Ruiterkamp-Versteeg, Nico Leijsten, Michael Kwint, Ronny Derks, Hilde Swinkels, Amber den Ouden, Rolph Pfundt, Tuula Rinne, Nicole de Leeuw, Alexander P. Stegmann, Servi J. Stevens, Arthur van den Wijngaard, Han G. Brunner, Helger G. Yntema, Christian Gilissen, Marcel R. Nelen, Lisenka E. L. M. Vissers

Summary: Genome sequencing (GS) is a technique that can provide novel diagnoses for patients who remain undiagnosed. In a study involving patients with neurodevelopmental disorders, GS and standard of care (SOC) had similar diagnostic yield, but GS identified two additional conclusive diagnoses and four additional possible diagnoses. GS comprehensively identified all variants in a single experiment, suggesting it is a more efficient genetic diagnostic workflow.

EUROPEAN JOURNAL OF HUMAN GENETICS (2023)

Article Genetics & Heredity

Clinical, neuroimaging and molecular characteristics of PPP2R5D-related neurodevelopmental disorders: an expanded series with functional characterisation and genotype-phenotype analysis

Nora Oyama, Pieter Vaneynde, Sara Reynhout, Emily M. Pao, Andrew Timms, Xiao Fan, Kimberly Foss, Rita Derua, Veerle Janssens, Wendy Chung, Ghayda M. Mirzaa

Summary: This study delineates the common features of PPP2R5D-related neurodevelopmental disorders, expands the clinical and molecular spectrum, and identifies genotype-phenotype correlations.

JOURNAL OF MEDICAL GENETICS (2023)

Article Genetics & Heredity

De novo mutation hotspots in homologous protein domains identify function-altering mutations in neurodevelopmental disorders

Laurens Wiel, Juliet E. Hampstead, Hanka Venselaar, Lisenka E. L. M. Vissers, Han G. Brunner, Rolph Pfundt, Gerrit Vriend, Joris A. Veltman, Christian Gilissen

Summary: We developed Meta-Domain HotSpot (MDHS) to identify mutation hotspots in protein domains and found three significantly enriched missense DNM hotspots in the ion transport protein domain family. These hotspots are associated with neurodevelopmental disorders and affect multiple genes.

AMERICAN JOURNAL OF HUMAN GENETICS (2023)

Article Biochemistry & Molecular Biology

Effect of exogenous IL-37 on immune cells from a patient carrying a potential IL37 loss-of-function variant: A case study

Lisa U. Teufel, Caspar van der Made, Viola Kluck, Annet Simons, Alexander Hoischen, Vivian Vernimmen, Leo A. B. Joosten, Rob J. W. Arts

Summary: A case study was conducted on a patient with a heterozygous stop-gain variant in the IL37 gene, which did not result in a clear pro-inflammatory phenotype in immune cells.

CYTOKINE (2023)

Article Oncology

Precision oncology using organoids of a secretory carcinoma of the salivary gland treated with TRK-inhibitors

Gerben Lassche, Adriana C. H. van Engen-van Grunsven, Onno van Hooij, Tilly W. Aalders, Jetty A. M. Weijers, Emiliano Cocco, Alexander Drilon, Alexander Hoischen, Kornelia Neveling, Jack A. Schalken, Gerald W. Verhaegh, Carla M. L. van Herpen

Summary: The use of anticancer drugs targeting specific molecular tumor characteristics is increasing, but selecting patients to benefit from these treatments remains challenging. Organoid cultures have been proposed as a suitable method to test drug responses in vitro. This study presents a case of secretory carcinoma of the salivary glands with ETV6-NTRK3 gene fusion and corresponding organoid cultures. The cultures initially responded to TRK targeting therapy, but later developed resistance. This case highlights the advancements in precision oncology and the limitations of using organoids in predicting treatment response.

ORAL ONCOLOGY (2023)

Article Genetics & Heredity

Identification of de novo variants in nonsyndromic cleft lip with/without cleft palate patients with low polygenic risk scores

Nina Ishorst, Leonie Henschel, Frederic Thieme, Dmitriy Drichel, Sugirthan Sivalingam, Sarah L. Mehrem, Ariane C. Fechtner, Julia Fazaal, Julia Welzenbach, Andre Heimbach, Carlo Maj, Oleg Borisov, Jonas Hausen, Ruth Raff, Alexander Hoischen, Michael Dixon, Alvaro Rada-Iglesias, Michaela Bartusel, Augusto Rojas-Martinez, Khalid Aldhorae, Bert Braumann, Teresa Kruse, Christian Kirschneck, Gerrit Spanier, Heiko Reutter, Stefanie Nowak, Lina Goelz, Michael Knapp, Andreas Buness, Peter Krawitz, Markus M. Noethen, Michael Nothnagel, Tim Becker, Kerstin U. Ludwig, Elisabeth Mangold

Summary: This study investigates the genetic mechanisms of nonsyndromic cleft lip with/without cleft palate (nsCL/P) and identifies new candidate genes through the detection of highly penetrant de novo variants (DNVs). By conducting a series of analyses and validations on a discovery sample of 50 nsCL/P patient/parent-trios, MDN1 and PAXIP1 were identified as top candidate genes.

MOLECULAR GENETICS & GENOMIC MEDICINE (2023)

Review Neurosciences

The Genetics of Intellectual Disability

Sandra Jansen, Lisenka E. L. M. Vissers, Bert B. A. de Vries

Summary: Intellectual disability (ID) affects around 2-3% of the general population and has significant societal impact. The identification of genetic causes for ID has traditionally been challenging, but advancements in genetic diagnostic technologies have greatly improved detection rates. This shift towards a genotype-first approach has revolutionized clinical practice.

BRAIN SCIENCES (2023)

Article Chemistry, Medicinal

C-glycosides analogues of the okadaic acid central fragment exert neuroprotection via restoration of PP2A-phosphatase activity: A rational design of potential drugs for Alzheimer?s disease targeting tauopathies

Raquel L. Arribas, Lucia Viejo, Isaac Bravo, Minerva Martinez, Eva Ramos, Alejandro Romero, Eva M. Garcia-Frutos, Veerle Janssens, Carmen Montiel, Cristobal de los Rios

Summary: Protein phosphatase 2A (PP2A) plays a crucial role in cellular processes and its deficiency is associated with severe pathologies. In Alzheimer's disease, the hyperphosphorylation of tau protein is linked to the depression of PP2A activity. Researchers have designed new ligands to prevent PP2A inhibition, with compound 10 showing the most promising outcomes.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2023)

Article Medicine, Research & Experimental

Human pancreatic cancer patients with Epithelial-to-Mesenchymal Transition and an aggressive phenotype show a disturbed balance in Protein Phosphatase Type 2A expression and functionality

Jos van Pelt, Bob Meeusen, Rita Derua, Liesbeth Guffens, Eric Van Cutsem, Veerle Janssens, Chris Verslype

Summary: Pancreatic ductal adenocarcinoma (PDAC) has a low survival and little therapeutic advancements are expected. Epithelial-to-Mesenchymal transition (EMT) and Protein Phosphatase Type 2A (PP2A) play a role in aggressive PDAC. This study investigates the relationship between PP2A expression signature and EMT, and explores treatment implications.

JOURNAL OF TRANSLATIONAL MEDICINE (2023)

Article Multidisciplinary Sciences

Structural mechanism for inhibition of PP2A-B56α and oncogenicity by CIP2A

Karolina Pavic, Nikhil Gupta, Judit Domenech Omella, Rita Derua, Anna Aakula, Riikka Huhtaniemi, Juha A. Maatta, Nico Hofflin, Juha Okkeri, Zhizhi Wang, Otto Kauko, Roosa Varjus, Henrik Honkanen, Daniel Abankwa, Maja Kohn, Vesa P. Hytonen, Wenqing Xu, Jakob Nilsson, Rebecca Page, Veerle Janssens, Alexander Leitner, Jukka Westermarck

Summary: This study reveals the molecular level details and structural mechanisms of PP2A-B56 alpha inhibition by the oncoprotein CIP2A. CIP2A displaces the PP2A-A subunit and forms a pseudotrimer, blocking the B56 alpha substrate binding site and stabilizing CIP2A protein.

NATURE COMMUNICATIONS (2023)

Article Genetics & Heredity

Whole genome sequencing for USH2A-associated disease reveals several pathogenic deep-intronic variants that are amenable to splice correction

Janine Reurink, Nicole Weisschuh, Alejandro Garanto, Adrian Dockery, L. Ingeborgh van den Born, Isabelle Fajardy, Lonneke Haer-Wigman, Susanne Kohl, Bernd Wissinger, G. Jane Farrar, Tamar Ben-Yosef, Fatma Kivrak Pfiffner, Wolfgang Berger, Marianna E. Weener, Lubica Dudakova, Petra Liskova, Dror Sharon, Manar Salameh, Ashley Offenheim, Elise Heon, Giorgia Girotto, Paolo Gasparini, Anna Morgan, Arthur A. Bergen, Jacoline B. ten Brink, Caroline C. W. Klaver, Lisbeth Tranebjaerg, Nanna D. Rendtorff, Sascha Vermeer, Jeroen J. Smits, Ronald J. E. Pennings, Marco Aben, Jaap Oostrik, Galuh D. N. Astuti, Jordi Corominas Galbany, Hester Y. Kroes, Milan Phan, Wendy A. G. van Zelst-Stams, Alberta A. H. J. Thiadens, Joke B. G. M. Verheij, Mary J. van Schooneveld, Suzanne E. de Bruijn, Catherina H. Z. Li, Carel B. Hoyng, Christian Gilissen, Lisenka E. L. M. Vissers, Frans P. M. Cremers, Hannie Kremer, Erwin van Wijk, Susanne Roosing

Summary: Whole genome sequencing combined with an improved variant interpretation pipeline was used to assess individuals suspected of having USH2A-associated disease, leading to the identification of causative variants and providing a conclusive genetic diagnosis for rare genetic conditions.

HUMAN GENETICS AND GENOMICS ADVANCES (2023)

Article Biochemistry & Molecular Biology

B & ouml;rjeson-Forssman-Lehmann syndrome: delineating the clinical and allelic spectrum in 14 new families

Vani Jain, Seow Hoong Foo, Stephen Chooi, Celia Moss, Richard Goodwin, Siren Berland, Angus J. Clarke, Sally J. Davies, Sian Corrin, Oliver Murch, Samantha Doyle, Gail E. Graham, Lynn Greenhalgh, Susan E. Holder, Diana Johnson, Ajith Kumar, Roger L. Ladda, Susan Sell, Amber Begtrup, Sally A. Lynch, Emma Mccann, Rune Ostern, Caroline Pottinger, Miranda Splitt, Andrew E. Fry

Summary: Borjeson-Forssman-Lehmann syndrome (BFLS) is an X-linked intellectual disability syndrome caused by variants in the PHF6 gene. In this study, 19 individuals from 15 families carrying likely pathogenic or pathogenic PHF6 variants were analyzed. The study revealed sex-specific differences in PHF6 variant types and locations, with affected males often having missense variants or small in-frame deletions, and affected females tending to have truncating variants or large deletions/duplications. The findings further contribute to the understanding of the genetic and phenotypic spectrum of BFLS.

EUROPEAN JOURNAL OF HUMAN GENETICS (2023)

Article Immunology

TLR9 ligand sequestration by chemokine CXCL4 negatively affects central B cell tolerance

Elif Cakan, Marie Dominique Ah Kioon, Yolanda Garcia-Carmona, Salome Glauzy, David Oliver, Natsuko Yamakawa, Andrea Vega Loza, Yong Du, Jean-Nicolas Schickel, Joshua M. Boeckers, Chao Yang, Alessia Baldo, Lionel B. Ivashkiv, Ryan M. Young, Louis M. Staudt, Krishna L. Moody, Kerstin Nundel, Ann Marshak-Rothstein, Caspar I. van der Made, Alexander Hoischen, Anthony Hayward, Marzia Rossato, Timothy R. D. J. Radstake, Charlotte Cunningham-Rundles, Changwan Ryu, Erica L. Herzog, Franck J. Barrat, Eric Meffre

Summary: TLR9 and CXCL4 play important roles in central B cell tolerance, with TLR9 regulating the removal of autoreactive clones and CXCL4 inhibiting TLR9 function by sequestering its ligands. The findings suggest that correcting defective TLR9 function may be a potential therapeutic strategy for restoring B cell tolerance in SSc patients.

JOURNAL OF EXPERIMENTAL MEDICINE (2023)

Article Pediatrics

Rapid exome sequencing as a first-tier test in neonates with suspected genetic disorder: results of a prospective multicenter clinical utility study in the Netherlands

Richelle A. C. M. Olde Keizer, Abderrahim Marouane, Wilhelmina Kerstjens-Frederikse, A. Chantal Deden, Klaske Lichtenbelt, Tinneke Jonckers, Marieke Vervoorn, Maaike Vreeburg, Lidewij Henneman, Linda de Vries, Richard Sinke, Rolph Pfundt, Servi J. C. Stevens, Peter Andriessen, Richard van Lingen, Marcel Nelen, Hans Scheffer, Daphne Stemkens, Cor Oosterwijk, Hans Kristian Ploos van Amstel, Willem de Boode, Wendy A. G. van Zelst-Stams, Geert W. J. Frederix, Lisenka E. L. M. Vissers

Summary: The introduction of rapid exome sequencing (rES) has improved clinical decision-making for critically ill neonates. A clinical utility study was conducted comparing rES to routine genetic testing, and the results showed that rES detected more conclusive genetic diagnoses in shorter time and reduced genetic diagnostic costs.

EUROPEAN JOURNAL OF PEDIATRICS (2023)

暂无数据